LAIR1 and cancer: Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is an immune inhibitory receptor, high levels of LAIR-1 expression are associated with poor cancer differentiation and overexpression of LAIR-1 was significantly associated with worse overall survival in HCC (39).